Bioavailability of avitriptan was found to decrease significantly when administered 5 min after a standard high fat meal. The studies described herein were carried out to gain insight into the mechanism of this food effect. A series of studies were conducted in humans to assess the effect of timing
THE EFFECT OF FOOD ON THE PHARMACOKINETICS OF THE BICALUTAMIDE (‘CASODEX’) ENANTIOMERS
✍ Scribed by I. D. COCKSHOTT; S. D. OLIVER; J. J. YOUNG; K. J. COOPER; D. C. JONES
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 132 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0142-2782
No coin nor oath required. For personal study only.
✦ Synopsis
Casodex' (bicalutamide) is an orally active, non-steroidal, pure antiandrogen; it is a racemate with antiandrogenic activity residing predominantly in the (R)-enantiomer. Healthy male volunteers (n=15) were administered single oral doses of bicalutamide (50 mg) after food and after fasting as part of a three-treatment, three-period, randomized cross-over study, with a 9 week washout. After fasting, plasma concentrations of (R)-bicalutamide were much higher than those of (S)-bicalutamide; the mean (R)-enantiomer C max (734 ng mL 71 ) was about nine times higher than the (S)enantiomer value (84 ng mL 71 ). The corresponding t max values were 19 and 3 h for (R)and (S)-bicalutamide respectively. Elimination of (R)-bicalutamide from plasma was monoexponential and slow (t 1/2 =5´8 d). Elimination of (S)-bicalutamide was biphasic in some volunteers but monophasic in others (terminal t 1/2 =1´2 d; n=11). There was no signi®cant eect of food on AUC, t max , or t 1/2 data for either enantiomer. The observed slightly higher values of C max for (R)-bicalutamide (14%) and (S)-bicalutamide (19%), when dosing with food, achieved statistical signi®cance. However, dierences of this magnitude are unlikely to be of any clinical relevance. These data indicate that `Casodex' can be taken without reference to meal-times; this may be of particular relevance for its indication in a disease of the elderly. &1997 by John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
BACKGROUND. Bicalutamide (Casodex) is a new nonsteroidal antiandrogen developed for use in patients with prostate cancer. The efficacy and tolerability of bicalutamide as monotherapy and as combination therapy for patients with advanced prostate cancer have been evaluated in randomized clinical tria
Twelve young (mean age 23 years, range 18-28) and 12 elderly (mean age 76 years, range 65-89) volunteers were given a single oral dose of 80 mg valsartan after an overnight fast. Each group consisted of six male and six female subjects. Mean systemic exposure to valsartan was higher in the elderly w
Reboxetine, (RS)-2-[(RS)-alpha-(2-ethoxyphenoxy)benzyl]morpholine methanesulphonate, is a racemic compound and consists of a mixture of the (R,R)- and (S,S)-enantiomers. The pharmacokinetics of reboxetine enantiomers were determined in a crossover study in three male beagle dogs. Each animal receive